Due TOMORROW! Discussion question only! No intro or conclusion

Healthcare Factors Behind Cost Curve and Supply Curve Shifts”  Please respond to the following: From the American Hospital Association Website , compare the healthcare-based factors in the issues that you reviewed that, in your opinion, cause the cost curve of healthcare to shift. Provide at least one (1) example showing the manner in which the cost curve shifts in your response. Suggest at least three (3) attributes that cause the supply curve in healthcare to fluctuate. Provide specific examples of each of the suggested attributes to support your response.

3 pg paper

Topic: Dementia 

Sources: 2 

Pages: 3 pgs double spaced

Minimum word count: 500

and a works cited page

Compare DNP and PhD Nurses

  

Compare the PhD and DNP degrees. Define the differences in roles and education associated with the two degrees. Describe future opportunities for DNP-prepared nurses.

power points presentation

Based on what you have learned so far this week, create a PowerPoint presentation (minimum 12 slides) with detailed notes for each slide that addresses each of the following points/questions. Be sure to completely answer all the questions. Use clear headings that allow your professor to know which bullet you are addressing on the slides in your presentation. Support your content with at least four (4) citations throughout your presentation. Make sure to reference the citations using the APA writing style for the presentation. Include a slide for your references at the end. Follow best practices for PowerPoint presentations (an example is in the Resources tab) related to text size, color, images, effects, wordiness, and multimedia enhancements. Explain the five stages of group development.  Describe the various information gathering methods a group may use. Explain the difference between a traditional work team and a self-managing work team.  Explain the various approaches managers can use to build team performance.

Petition Letter

 Follow instructions carefully: I live in Homestead, Florida. county Miami Dade. Sample letter is being attached. grading eval is being attached. Thank you. 

Identify which two senators represent your state(FLORIDA) and who the congressional representative is for the district you live in. Of these three, who do you feel would be most sympathetic to your health policy issue?

Health Policy issue: Prescription drug Abuse

Write a 570-word petition letter to your senator or congressional representative regarding a health policy bill you would like to propose to address your selected health policy issue.

Include the following in your letter:

Identify who you are and who you represent.

Clearly define the issue that needs to be addressed, providing evidence that establishes the sense of urgency to take action.

Layout your proposal for legislation that will address the issue.

Provide at least two strong arguments that could persuade your senator or representative to support and hopefully introduce your proposal as a bill into the legislative process.

Utilize the articles you selected in prior weeks to support your proposal. 

Research at least one opposing argument by locating academic articles using the University Library and provide a detailed response to your opposition’s argument.

If there is currently any active legislation that would negatively affect your selected issue, identify the legislation and explain why your senator or representative should vote against its passage. 

Close out your letter by addressing how your proposed legislation may influence outcomes.

Utilize Box 44-2: Sample Letter/E-Mail to a Policymaker located on p. 396 in Ch. 44 of Policy & Politics as a guide.

Cite and reference using APA guidelines.

Need appropriate APA REFRENCE

Me    6 posts   Re: Topic 4 DQ 1  I agree with you that the first step to bringing about change in the community is to know the community. One should acknowledge and understand the need for such change. It is usually very tempting to see that something needs fixing and quickly jump into a solution. One should resist this temptation and instead take the time to study the community to get a clear understanding of all the needed change.I, further, agree with you that understanding the healthcare system at the local level involves important questions such as those you mentioned. One needs to understand the services offered in the community so that they can be effective while implementing evidence-based practice. To implement the right change in the community, it is important for the healthcare professionals to put their biases aside and talk to the people on the ground, to get a good understanding of what matters most to the citizens. In the long run, this prevents the implementation of underused EBP initiatives (Saunders & Vehviläinen-Julkunen, 2018). Carrying out such an assessment for the community will help in the identification of the available community resources and how those services can be accessed for the benefit of the patient.I also agree with the insights of your mentor about the importance of focusing on lead education especially in this day and age. I think than this is an area that has not received a lot of attention and tends to be ignored yet it is very important especially for community health. Basing your research in this field will add to the exiting limited knowledge hence contribute to the future body of research. Generally, I find your post to be very informative. All the best.  References  Saunders, H., & Vehviläinen-Julkunen, K. (2018). Key considerations for selecting instruments when evaluating healthcare professionals’ EBP competencies: A discussion paper. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/30019462

This is what I need 

Terri O’Brien    25 posts   Alimatu – substantive credit and APA  Alimatu  As your link contains the journal name and other information, please revisit the link and then provide a complete reference in APA format so I can give you credit for this post.  Thank you.

this is what  i need

Discussion Response to Addison's disease 180-200 words APA

According to Huether and McCance (2017), Addison’s disease is an auto-immune disorder marked by adrenal insufficiency and is more common in white women than all ethnicities of men. Relatively rare, this disease most often occurs between the ages of 30-60 (Huether &McCance, 2017). Addison’s disease is an inherited disorder, however, research on the pathway of genetic inheritability has been limited because the genotype of a patient does not always predict their phenotype and the rarity of disease inhibits large scale genetic analysis (Mitchell & Pearce, 2012).  According to Mitchell and Pearce (2012), it is a progressive disease with symptoms developing over months or years. Initial clinical manifestations of disease will appear in the increase of adrenocorticotropic hormone and renin well before adrenal failure develops (Mitchell & Pearce, 2012). 

     Pathological changes of the adrenal glands (including adrenal atrophy) are combined with fatigue, hypotension, weight loss and hyper skin pigmentation (Mitchell & Pearce, 2012). The steroidogenic enzymes in the adrenal cortex of the patient with Addison’s disease become targets for the immune system to attack (Mitchell & Pearce, 2012). The presence of circulating steroid 21-hydroxylase antibodies is a reliable predictor of Addison’s Disease, this is normally located on the smooth endoplasmic reticulum of intact cells (Mitchell & Pearce, 2012).  This can lead to other autoimmune responses in the body, metastatic malignancy, amyloidosis, hemorrhage, infections, adrenoleuko dystrophy, or sarcoidosis. Other clinical manifestations include low levels of cortisol in serum and urine tests, increased ACTH levels, BUN increases (due to dehydration), Eosinophil and lymphocyte elevations, hyperkalemia and mild alkalosis (Huether & McCance, 2017). Treatment involves glucocorticoid and mineralocorticoid replacement for life as well as increases in sodium intake if patient experiences excessive sweating and diarrhea.

References

Huether, S. E., & McCance, K. L. (2017). Understanding Pathophysiology(6th ed.). St. Louis, 

MO: Mosby.

Mitchell, A. L., & Pearce, S. H. S. (2012). Autoimmune Addison disease: pathophysiology and 

genetic complexity. Nature Reviews. Endocrinology, 8(5), 306–316. https://doi-org.ezp.waldenulibrary.org/10.1038/nrendo.2011.245

U4D2

  Cultural Competence

To provide quality healthcare to the entire population, healthcare workers and educators must be competent in their understanding of the relevant characteristics for the ethnic groups represented. This is true both of individuals and of the organizational culture as a whole. For this discussion, consider the following: What is cultural competence and what are its benefits to the patient, staff, and healthcare organization? Identify evidence-based strategies that organizations could employ to establish and maintain cultural competence. What barriers exist regarding cultural competence and how might they be overcome? Describe the cultural competence of your organization. How might it affect the content of or quality of the outcome of your Unit 5 assignment? Reflect on your personal cultural competence. What things will you personally need to be aware of as you complete your Unit 5 assignment?

the topic chosen is high risk pregnant women with multimorbidities and risks. 

  

My program is an individual model of integrated care. This group of integrated care model is concerned with coordination of individual care for patients with multiple conditions or high-risk patients. The reason for choosing individual models of integrated care is that it facilitates appropriate delivery of health services and overcomes fragmentations between health care providers. Additionally, coordination for patients’ care in this model goes beyond a single episode of care, where it coordinates between different providers alongside embracing the concept of integration across life-course.

must be at least 150 words with at least 1 APA formatted reference in the post and as a reference. 

Leadership week 4 discussion

  Discuss delegation and supervision in the health care system.

Discussion: Off-Label Drug Use in Pediatrics

The unapproved use of approved drugs, also called off-label use, with children is quite common. This is because pediatric dosage guidelines are typically unavailable since very few drugs have been specifically researched and tested with children.

When treating children, prescribers often adjust dosages approved for adults to accommodate a child’s weight. However, children are not just “smaller” adults. Adults and children process and respond to drugs differently in their absorption, distribution, metabolism, and excretion. Children even respond differently during stages from infancy to adolescence. This poses potential safety concerns when prescribing drugs to pediatric patients. As an advanced practice nurse, you have to be aware of safety implications of the off-label use of drugs with this patient group. To prepare: Review the Bazzano et al. and Mayhew articles in the Learning Resources. Reflect on situations in which children should be prescribed drugs for off-label use. Think about strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Consider specific off-label drugs that you think require extra care and attention when used in pediatrics.

With these thoughts in mind: By Day 3

Post an explanation of circumstances under which children should be prescribed drugs for off-label use. Then, describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.

CLASS RESOURCES  Arcangelo,  V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.).  (2017). Pharmacotherapeutics for advanced  practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams  & Wilkins.
Review Chapter 4, “Principles of Pharmacotherapy in Pediatrics” (pp. 53-63)
This chapter explores concepts relating to drug selection, administration, and interaction for pediatric patients. It also compares age-related pharmacokinetic differences in children and adults.

Chapter 17, “Ophthalmic Disorders” (pp. 221-243)
This chapter examines the causes, pathophysiology, diagnostic criteria, and drug treatment for four ophthalmic disorders: blepharitis, conjunctivitis, keratoconjunctivitis sicca, and glaucoma. It also explores methods of monitoring patient response to treatment.

Chapter 43, “Attention-Deficit/Hyperactivity Disorder” (pp. 743-756)  
This chapter explains the process of diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD). It also identifies drugs for treating patients with ADHD, including proper dosages, selected adverse events, and special considerations for each drug.

Chapter 51, “Immunizations” (pp. 906-926)  
This chapter explores vaccines that are licensed for use in the United States and provides a recommended vaccination schedule for pediatric patients and adults.

Chapter 52, “Smoking Cessation” (pp. 927-943)  
This chapter examines clinical implications of smoking. It also covers various approaches for aiding patients who are dependent on nicotine but want to stop smoking.

Chapter 54, “Weight Loss” (pp. 945-956)  
This chapter begins by reviewing patient factors that contribute to obesity. It also examines drug therapy for initiating weight loss in patients, as well as alternative non-drug treatments. Bazzano, A. T, Mangione-Smith, R., Schonlau, M., Suttorp, M. J., & Brook, R. H. (2009). Off-label prescribing to children in the United States outpatient setting. Academic Pediatrics, 9(2), 81–88.
Note: Retrieved from the Walden Library databases.

This study examines the frequency of off-label prescribing to children and explores factors that impact off-label prescribing. Mayhew, M. (2009). Off-label prescribing. The Journal for Nurse Practitioners, 5(2), 122–123.
Note: Retrieved from the Walden Library databases.

This article reviews the prevalence of off-label prescribing, including its benefits and risks. It also explores issues regarding the safety of off-label prescribing and when it is unavoidable. Drugs.com. (2012). Retrieved from http://www.drugs.com/

This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.